Author:
Agrawal Amit Kumar,Noronha Vanita,Patil Vijay,Menon Nandini,Kapoor Akhil,Chougule Anuradha,Chandrani Pratik,Prabhash Kumar
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Crispo F, Notarangelo T, Pietrafesa M, Lettini G, Storto G, Sgambato A, Maddalena F, Landriscina M (2019) Braf inhibitors in thyroid cancer: clinical impact, mechanisms of resistance and future perspectives. Cancers 11(9):1388
2. DeGroot LJ, Larsen PR, Hennemann G (1996) The thyroid and its diseases. WB Saunders Company, Philadelphia
3. Kondo T, Ezzat S, Asa SL (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6(4):292–306
4. DeLellis RA (ed) (2004) Pathology and genetics of tumours of endocrine organs. IARC, Lyon
5. Wang W, Macapinlac H, Larson SM, Yeh SD, Akhurst T, Finn RD, Rosai J, Robbins RJ (1999) [18F]-2-fluoro-2-deoxy-d-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab 84(7):2291–2302
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献